Australia markets closed

Sumitomo Pharma Co., Ltd. (DNPUF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
4.30000.0000 (0.00%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Cash flows from operating activities
Net income
-314,969,000
-314,969,000
-74,512,000
56,413,000
56,219,000
-
Depreciation & amortisation
37,765,000
37,765,000
41,263,000
38,348,000
22,673,000
-
Change in working capital
-51,715,000
-51,715,000
34,878,000
-33,733,000
66,327,000
-
Inventory
-11,795,000
-11,795,000
4,560,000
5,356,000
-10,039,000
-
Other working capital
-257,623,000
-257,623,000
-805,000
17,745,000
124,795,000
-
Other non-cash items
-43,078,000
-43,078,000
-41,959,000
-9,984,000
8,325,000
-
Net cash provided by operating activities
-241,893,000
-241,893,000
11,937,000
31,239,000
135,601,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-15,730,000
-15,730,000
-12,742,000
-13,494,000
-10,806,000
-
Acquisitions, net
-2,469,000
-2,469,000
0
-
-
-205,774,000
Purchases of investments
-4,772,000
-4,772,000
-6,247,000
-25,905,000
-9,366,000
-
Sales/maturities of investments
34,499,000
34,499,000
10,068,000
19,472,000
8,141,000
-
Other investing activities
-
-
2,047,000
-1,124,000
225,000
23,000
Net cash used for investing activities
33,036,000
33,036,000
52,419,000
-18,278,000
8,875,000
-
Net change in cash
-131,006,000
-131,006,000
-82,461,000
-8,465,000
87,261,000
-
Cash at beginning of period
143,478,000
143,478,000
202,984,000
193,698,000
101,708,000
-
Cash at end of period
29,047,000
29,047,000
143,478,000
202,984,000
193,698,000
-
Free cash flow
Operating cash flow
-241,893,000
-241,893,000
11,937,000
31,239,000
135,601,000
-
Capital expenditure
-15,730,000
-15,730,000
-12,742,000
-13,494,000
-10,806,000
-
Free cash flow
-257,623,000
-257,623,000
-805,000
17,745,000
124,795,000
-